Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gerber

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Journal of Neuro-Oncology|January 11, 2014
Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocolCarsten Friedrich, Klaus Müller, Katja von Hoff, et al.
The Journal of Nutrition, Health & Aging|May 7, 2004
Treatment and care of patients with chronic severe brain damage. Medical-ethical guidelines of the Swiss Academy of Medical ScienceH B Staehelin, Hannes Stähelin, Alberto Bondolfi, et al.
Journal of Neurosurgery. Pediatrics|August 3, 2010
Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT databaseMartin Benesch, Daniela Weber-Mzell, Nicolas U Gerber, et al.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Journal of Neuro-Oncology|February 11, 2011
Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006Nicolas U Gerber, Katja von Hoff, André O von Bueren, et al.
Neuro-Oncology|June 4, 2011
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histologyAndré O von Bueren, Katja von Hoff, Torsten Pietsch, et al.
BMC Cancer|February 18, 2011
c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patientsAndré O von Bueren, Christoph Oehler, Tarek Shalaby, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapyNicolas U Gerber, Katja von Hoff, Anika Resch, et al.
Neuro-Oncology|December 11, 2012
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapyCarsten Friedrich, André O von Bueren, Katja von Hoff, et al.
The American Journal of Surgical Pathology|August 30, 2008
Hypothalamic papillary tumor in a patient with tuberous sclerosisMartin Hasselblatt, Jaroslaw Jozwiak, Karin Mayer, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Journal of Neuro-Oncology|January 11, 2014
Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocolCarsten Friedrich, Klaus Müller, Katja von Hoff, et al.
The Journal of Nutrition, Health & Aging|May 7, 2004
Treatment and care of patients with chronic severe brain damage. Medical-ethical guidelines of the Swiss Academy of Medical ScienceH B Staehelin, Hannes Stähelin, Alberto Bondolfi, et al.
Journal of Neurosurgery. Pediatrics|August 3, 2010
Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT databaseMartin Benesch, Daniela Weber-Mzell, Nicolas U Gerber, et al.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Journal of Neuro-Oncology|February 11, 2011
Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006Nicolas U Gerber, Katja von Hoff, André O von Bueren, et al.
Neuro-Oncology|June 4, 2011
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histologyAndré O von Bueren, Katja von Hoff, Torsten Pietsch, et al.
BMC Cancer|February 18, 2011
c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patientsAndré O von Bueren, Christoph Oehler, Tarek Shalaby, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapyNicolas U Gerber, Katja von Hoff, Anika Resch, et al.
Neuro-Oncology|December 11, 2012
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapyCarsten Friedrich, André O von Bueren, Katja von Hoff, et al.
The American Journal of Surgical Pathology|August 30, 2008
Hypothalamic papillary tumor in a patient with tuberous sclerosisMartin Hasselblatt, Jaroslaw Jozwiak, Karin Mayer, et al.
Pageof 19